A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells
CD4+Foxp3+ regulatory T cells (Tregs) are essential for maintaining immune tolerance, and selective expansion of Tregs via TNFR2 signaling represents a promising therapeutic approach for autoimmune and inflammatory diseases. Here, we report the identif…